Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 21318603)

  • 1. Relationship between ERCC1 and XPC polymorphisms and the susceptibility to head and neck carcinoma: A systematic review, meta-analysis, and trial sequential analysis.
    Imani MM; Akbari S; Shalchi M; Sadeghi E; Sadeghi M
    Arch Oral Biol; 2024 Jun; 162():105955. PubMed ID: 38479279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of XPC Gene Polymorphisms with Colorectal Cancer Risk in a Southern Chinese Population: A Case-Control Study and Meta-Analysis.
    Hua RX; Zhu J; Jiang DH; Zhang SD; Zhang JB; Xue WQ; Li XZ; Zhang PF; He J; Jia WH
    Genes (Basel); 2016 Sep; 7(10):. PubMed ID: 27669310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of Exo1 K589E polymorphism on cancer susceptibility: evidence based on a meta-analysis.
    Duan F; Song C; Dai L; Cui S; Zhang X; Zhao X
    PLoS One; 2014; 9(5):e96764. PubMed ID: 24810280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A protein interaction landscape of breast cancer.
    Kim M; Park J; Bouhaddou M; Kim K; Rojc A; Modak M; Soucheray M; McGregor MJ; O'Leary P; Wolf D; Stevenson E; Foo TK; Mitchell D; Herrington KA; Muñoz DP; Tutuncuoglu B; Chen KH; Zheng F; Kreisberg JF; Diolaiti ME; Gordan JD; Coppé JP; Swaney DL; Xia B; van 't Veer L; Ashworth A; Ideker T; Krogan NJ
    Science; 2021 Oct; 374(6563):eabf3066. PubMed ID: 34591612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.
    Dai Y; Song Z; Zhang J; Gao W
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31710080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential risk of esophageal squamous cell carcinoma due to nucleotide excision repair XPA and XPC gene variants and their interaction among themselves and with environmental factors.
    Rafiq R; Bhat GA; Lone MM; Masood A; Dar NA
    Tumour Biol; 2016 Aug; 37(8):10193-207. PubMed ID: 26831662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.
    Wu H; Lv Z; Wang X; Zhang L; Mo N
    Int J Clin Exp Med; 2015; 8(10):17959-67. PubMed ID: 26770390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XPC Lys939Gln and Ala499Val polymorphisms in colorectal cancer susceptibility: a meta-analysis of case-control studies.
    Liu C; Yin Q; Ying M; Lin J; Li L; Jiao G; Wang M; Wang Y
    Mol Biol Rep; 2014 Feb; 41(2):1171-8. PubMed ID: 24385304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the XPC gene may contribute to the risk of head and neck cancer: a meta-analysis.
    Zhang Y; Li Z; Zhong Q; Zhou W; Chen X; Chen X; Fang J; Huang Z
    Tumour Biol; 2014 Apr; 35(4):3917-31. PubMed ID: 24338715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of the association between XPC Lys939Gln polymorphism and cutaneous melanoma risk.
    Zhou L; Lu Y; Yang G; Wu J
    Tumour Biol; 2014 Feb; 35(2):1427-32. PubMed ID: 24277375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. XPC Polymorphism Increases Risk of Digestive System Cancers: Current Evidence from A Meta-Analysis.
    Jiang X; Zhou LT; Zhang SC; Chen K
    Chin J Cancer Res; 2012 Sep; 24(3):181-9. PubMed ID: 23359774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the ERCC5 Asp1104His polymorphism and cancer risk: a meta-analysis.
    Zhu ML; Wang M; Cao ZG; He J; Shi TY; Xia KQ; Qiu LX; Wei QY
    PLoS One; 2012; 7(7):e36293. PubMed ID: 22815677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of XPC polymorphisms with susceptibility and clinical outcome to chemotherapy in breast cancer patients.
    Yang X; Liu D; Wu H; Kang H; Pang H; Huang D; Sha X; Wang E; Wang Z; Wei M
    Cancer Sci; 2012 Jul; 103(7):1207-14. PubMed ID: 22519360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W; Cong XF; Cai WH; Yang S; Mao C; Zou HW
    Breast Cancer Res Treat; 2011 Aug; 128(3):811-5. PubMed ID: 21318603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX; Yao L; Zhang J; Zhu XD; Zhao XM; Xue K; Mao C; Chen B; Zhan P; Yuan H; Hu XC
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX; Yao L; Mao C; Chen B; Zhan P; Yuan H; Xue K; Zhang J; Hu XC
    Breast Cancer Res Treat; 2010 Sep; 123(2):543-7. PubMed ID: 20143154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis.
    Francisco G; Menezes PR; Eluf-Neto J; Chammas R
    Eur J Hum Genet; 2008 Jun; 16(6):724-34. PubMed ID: 18285822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between XPC polymorphisms and risk of cancers: A meta-analysis.
    Qiu L; Wang Z; Shi X; Wang Z
    Eur J Cancer; 2008 Oct; 44(15):2241-53. PubMed ID: 18771913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX; Mao C; Yao L; Yu KD; Zhan P; Chen B; Liu HG; Yuan H; Zhang J; Xue K; Hu XC
    Breast Cancer Res Treat; 2010 Jul; 122(2):489-93. PubMed ID: 20049524
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.